University of Illinois College of Medicine

Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer

Retrieved on: 
Tuesday, October 10, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Immunosuppression, TME, Pancreatitis, SOC, Cedars-Sinai Medical Center, AACR, Standard of care, LAPC, University, Survival, Disease, Abdominal pain, Nausea, University of Illinois College of Medicine, Immunotherapy, Pancreatic cancer, LSAM, Immunomodulation, Paclitaxel, Plasma, Parkview Health, Illinois College, Tumor necrosis factor, Tissue, NK, Phenotype, Blood, Conference, Research, Pharmaceutical industry, Dietary supplement, Vaccine, Medical device, Medical imaging, Pancreas, MD, Safety

The research article entitled Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome provides safety and response data from dose escalation and 2-injection cohorts.

Key Points: 
  • The research article entitled Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome provides safety and response data from dose escalation and 2-injection cohorts.
  • “Pancreatic cancer is among the most lethal cancers with 5-year survival of only 12%,” said lead investigator and author, Neil Sharma, MD.
  • The research article reports data from evaluable subjects in the first two cohorts while the third is pending final readout.
  • Additionally, two posters presented downstaging and immune data from the Phase 2 trial following IT LSAM-PTX at the recent AACR Special Conference on Pancreatic Cancer.

Emergency department overcrowding: Can AI, predictive modeling and simulation fix it?

Retrieved on: 
Thursday, July 6, 2023
Pressure, Communication, University, College, Bed, Nursing, Engineering, EMR, Outcomes research, ARCHES, Grainger College of Engineering, Kang, The College of Medicine, COVID-19, Sister, Fred Hutchinson Cancer Research Center, Research, Multimedia, OSF HealthCare, University of Illinois Urbana-Champaign, Doctor of Philosophy, Forecasting, Museum, Hospital, Illinois College, MD, Patient, OSF, Machine learning, Missionary, University of Illinois College of Medicine, Champaign–Urbana metropolitan area, Physician, Virtual reality, Data, Weather, Applied science, Third order, Health, ED, UIUC, Community health, Safety, Management

PEORIA, Ill., July 6, 2023 /PRNewswire/ -- It seems almost everyone has a story about how long they had to wait to receive care in an emergency department due to overcrowding. In fact, research shows patient congestion is one of the main factors threatening efficiency, safety and quality of care.

Key Points: 
  • William Bond, MD, is an emergency department (ED) physician at OSF HealthCare Saint Francis Medical Center in Peoria, Illinois.
  • He also directs simulation research at Jump Simulation , a collaborative effort between OSF and the University of Illinois College of Medicine Peoria (UICOMP).
  • The project is called: STREAM-ED: Simulation to Refine, Enhance and Adapt Management of Emergency.
  • They'll also use data about physical resources and providers, including nurses and technicians who deliver assessments or care in different pods within the emergency department.

Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease

Retrieved on: 
Monday, March 6, 2023
MHA, MD, Technology management, Cytokine, Pharmacy, MBA, Illinois College, Therapy, Discovery Partners Institute, Cell, Chemokine, Neutrophil, Antibody, Eye, Visual impairment, College, B cell, Interferon gamma, Patient, Plasma, National Eye Institute, University of Illinois College of Medicine, Telecanthus, NEI, University, FDA, Doctor of Philosophy, UIC College of Pharmacy, Inflammation, UIC, University of Illinois at Chicago, NIH, Pharmaceutical industry, Vaccine, Grifols, Ophthalmology, Research

The anti-inflammatory actions of eye drops that are currently approved for treating chronic dry eye disease are narrow-spectrum and limited primarily to targeting T-cell inflammatory mechanisms.

Key Points: 
  • The anti-inflammatory actions of eye drops that are currently approved for treating chronic dry eye disease are narrow-spectrum and limited primarily to targeting T-cell inflammatory mechanisms.
  • "We are so delighted that this novel application of immunoglobulin eye drops to treat dry eye disease has resulted from Dr. Sandeep Jain's world-class and innovative research work.
  • This new sublicense agreement between Selagine and Grifols will facilitate the continued development of this therapeutic to potentially help the millions of patients around the world suffering from dry eye disease."
  • In addition, Grifols has committed to fund the development of immunoglobulin eye drops through FDA approval, which will be managed collaboratively by Grifols and Selagine, including the clinical, manufacturing and regulatory activities required for FDA approval for dry eye disease indication.

Dr. Stephanie Toth-Manikowski Named Corporate Medical Director of Healthmap Solutions

Retrieved on: 
Wednesday, November 2, 2022
Johns Hopkins Bloomberg School of Public Health, Barrier, Pregnancy, Health, CEO, National Kidney Foundation, Internal medicine, Chronic kidney disease, Compassion, Master of Health Science, GLOBE, Research, Boston Medical Center, Society, A.C.E, Johns Hopkins, COVID-19, Dialysis, American Society of Nephrology, Accountable care organization, University of Illinois College of Medicine, Renal replacement therapy, Kidney disease, University, NCQA, Public health, Assistant, CKD, Altruism, Patient, UIC, Kidney, Journal, UIC College of Pharmacy, MHS, Acos, American Association of Clinical Endocrinologists, Cardiology, Harvard College, Medicine, Medical device, Pharmaceutical industry, MD, Nephrology, Biology, Medicine, HealthMap

TAMPA, Fla., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Nephrologist Stephanie Toth-Manikowski, MD, MHS, has joined Healthmap Solutions (Healthmap) as Corporate Medical Director, with a national scope of work that includes identifying advanced kidney healthcare best practices across patient populations.

Key Points: 
  • TAMPA, Fla., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Nephrologist Stephanie Toth-Manikowski, MD, MHS, has joined Healthmap Solutions (Healthmap) as Corporate Medical Director, with a national scope of work that includes identifying advanced kidney healthcare best practices across patient populations.
  • In her new role with Healthmap, she will provide some key areas of focus to include:
    Early Identification: Strengthening data-driven techniques for early identification of kidney disease.
  • Provider/Patient Relationships: Developing collaborative and transparent processes across the Healthmap organization that earn ongoing trust from healthcare providers and the member patients under their care.
  • We are delighted that Dr. Toth-Manikowski is joining our clinical team in our ongoing pursuit of innovative and value-based kidney care solutions.

Complex Knee Surgeon, Robert LaPrade, MD, PhD, Ranks Among the Top Orthopedic Researchers in the World as h-index Surpasses 100

Retrieved on: 
Tuesday, August 30, 2022
University, Google Scholar, MCL, British Journal of Sports Medicine, List of Nobel laureates, Orthopedic surgery, AJSM, Meniscus, Knee, Doctor of Philosophy, Fibular collateral ligament, Sports medicine, Professor, ISAKOS, University of Illinois College of Medicine, Physician, ALL, Cartilage, Textbook, Anatomy, Student, David Ferrer (racing driver), ACL, Anterior cruciate ligament, Illinois College, MD, Nobel Prize, Surgeon, Publication, American Journal, Google, Elective surgery, Posterior cruciate ligament, PCL, Medial knee injuries, Patient, Dentistry, Research

EDINA, Minn., Aug. 30, 2022 /PRNewswire-PRWeb/ -- Complex knee surgeon and research clinician scientist, Robert LaPrade, MD, PhD, joins the list of most highly cited researchers (h-index => 100 according to his public profile in the Google Scholar Citations database). A high h-index value signifies Dr. LaPrade's leadership in the Orthopedic field and underscores the degree to which his research has advanced and inspired the work of peer scientists. An h-index of 100 indicates that Dr. LaPrade has published 100 papers that have each received 100 or more citations 100 or more times. When a paper is frequently cited, it demonstrates that other researchers and orthopedists are using those results to test and prove new theories that subsequently provide fresh discoveries. This process is how research serves as the basis for continuously advancing the field of orthopedics and improving outcomes.

Key Points: 
  • Dr. Robert LaPrade, researcher and complex knee surgeon, reaches an h-index of over 100 with at least 100 articles cited at least 100 times.
  • EDINA, Minn., Aug. 30, 2022 /PRNewswire-PRWeb/ -- Complex knee surgeon and research clinician scientist, Robert LaPrade, MD, PhD , joins the list of most highly cited researchers (h-index => 100 according to his public profile in the Google Scholar Citations database ).
  • An h-index of 100 indicates that Dr. LaPrade has published 100 papers that have each received 100 or more citations 100 or more times.
  • This process is how research serves as the basis for continuously advancing the field of orthopedics and improving outcomes.

OSF HealthCare collaborates to test blockchain-based app to reward healthy behaviors

Retrieved on: 
Tuesday, May 10, 2022
Champaign County, Illinois, Innovation, Nursing, Privacy, Museum, Data, Grainger College of Engineering, Business, Outcomes research, University, Student, Health, Third order, Bed, UIUC, Research, Blockchain, Physician, College, ARCHES, German Cancer Research Center, Faculty, Gies College of Business, Sister, Diagnosis, Hospital, University of Cincinnati College of Engineering and Applied Science, Virtual reality, Behavior, University of Illinois Urbana-Champaign, Immersion, Center, OSF, University of Illinois College of Medicine, Education, Applied science, Solution, College of Medicine (UK), Partner (business rank), Technology, Community health, OSF HealthCare, Multimedia, Illinois College, Management, Cryptocurrency, Video game console, Online shopping, Pharmaceutical industry, Medicine, Jump, Engineering

Ralph says consumers using the blockchain-based rewards app could be rewarded quickly for exercising, taking medication, or any number of other healthy behaviors, unlike the kinds of programs insurance companies currently offer clients.

Key Points: 
  • Ralph says consumers using the blockchain-based rewards app could be rewarded quickly for exercising, taking medication, or any number of other healthy behaviors, unlike the kinds of programs insurance companies currently offer clients.
  • Other systems (insurance reward programs), will take a lot longer and it'll be harder to see directly the impact of what you're doing."
  • OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health and hospice services.
  • Jump Trading Simulation and Education Center, a part of OSF Innovation , is a collaboration between University of Illinois College of Medicine at Peoria and OSF HealthCare.

Latest Jump ARCHES awards focus on medical tech solutions to address vexing health care challenges

Retrieved on: 
Thursday, January 20, 2022
Medicine, Champaign County, Illinois, Research, OSF HealthCare, Data, Partner (business rank), Museum, University of Illinois Urbana-Champaign, College of Medicine (UK), Physician, Athlete, Concussion, Outcomes research, University of Illinois College of Medicine, Technology, COVID-19, Social, Third order, Digital health, Student, Kansas State University College of Engineering, Psychiatry Innovation Lab, Multimedia, Applied science, Hospital, Intubation, Grainger College of Engineering, Partnership, Health literacy, News, Sister, Solution, Health, Center, Child, Education, Illinois College, Behavioural sciences, College, German Cancer Research Center, Nursing, FAAP, CSBS, Migraine, Engineering, IOT, Poverty, Bed, OSF, View, Community health, Faculty, University, Virtual reality, ARCHES, Pharmaceutical industry, Jump, MD

The funding supports research involving clinicians, engineers, and social scientists to rapidly develop technologies and devices that could revolutionize medical training and health care delivery.

Key Points: 
  • The funding supports research involving clinicians, engineers, and social scientists to rapidly develop technologies and devices that could revolutionize medical training and health care delivery.
  • He adds, "We know digitally connected health systems, powerful data analytics, and new innovative approaches offer the promise of universal standard care and health knowledge for everyone we serve."
  • HCESC designs collaborative solutions to improve health care outcomes utilizing their expertise in simulation technologies, smart health systems, data analytics, human factors and medical robotics.
  • HCESC partners with Jump in this innovative relationship of Applied Research for Community Health through Engineering and Simulation (ARCHES).

Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors

Retrieved on: 
Monday, October 25, 2021
Amos, TEL, MD, Cancer, Radiation, Radiation therapy, University, LinkedIn, Medical degree, Hematology, College, American Board of Radiology, Colorectal cancer, Independent director, Board of directors, Nuclear Medicine, Oncology and Radiotherapy Institute, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Security (finance), Ministry of Health (Malaysia), Policy, Ministry, ABR, Government, Central Waqf Council, OTCQB, Time, Company, Instagram, Board, OTC, University of Illinois College of Medicine, Exchange, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Report, American Board of Commissioners for Foreign Missions, Pharmaceutical industry, Medical device

Dr. Tova specializes in treating cancer with radiation, using radiation therapy to treat a wide variety of cancers.

Key Points: 
  • Dr. Tova specializes in treating cancer with radiation, using radiation therapy to treat a wide variety of cancers.
  • Dr. Tova is certified by the American Board of Radiology (ABR), and currently serves as Director of the Radiotherapy Institute at Ziv Hospital in Israel.
  • Company Director and Head of Advisory Board, Dr. Gil Feiler, commented: "It is with great pleasure that I welcome Dr. Yonina Tova to our Advisory Board.
  • For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Instagram @Cannabics_Pharmaceuticals.

Enduvo Recognized by Training Industry As A Learning Experience Platform (LXP) Company to Watch

Retrieved on: 
Thursday, September 9, 2021

CHICAGO, Sept. 9, 2021 /PRNewswire-PRWeb/ -- Enduvo announces that Training Industry , the most trusted source of information on the business of learning, recognizes Enduvo's no-code XR learning platform as one to watch.

Key Points: 
  • CHICAGO, Sept. 9, 2021 /PRNewswire-PRWeb/ -- Enduvo announces that Training Industry , the most trusted source of information on the business of learning, recognizes Enduvo's no-code XR learning platform as one to watch.
  • According to Training Industry , Learning Experience Platform (LXP) is the latest evolution of training technology.
  • These systems focus on user experience, enhancing the usability and efficiency of the learning experience, and enabling learners to seamlessly interact with multiple types of learning content in one platform.
  • The Training Industry annual list of companies to watch aims to help buyers of training services evaluate Learning Experience Platform (LXP) providers.

OSF HealthCare and UIC Partner to Expand Research to Improve Health and Wellness in Chicago and Collar Counties; Other Urban Communities

Retrieved on: 
Thursday, July 22, 2021
Health care, Health, Illinois, OSF Healthcare, Peoria, Illinois, OSF, University of Illinois College of Medicine, Hospice, OSF Saint Francis Medical Center

"By adding the clinical expertise at OSF, we will develop new products and approaches to accelerate health care innovation."

Key Points: 
  • "By adding the clinical expertise at OSF, we will develop new products and approaches to accelerate health care innovation."
  • "UIC is the principal educator of health science professionals in Illinois and a major healthcare provider to underserved communities in Chicago and beyond.
  • OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health and hospice services.
  • Jump Simulation, a part of OSF Innovation,is a collaboration between University of Illinois College of Medicine Peoria and OSF HealthCare.